Price Consolidation: Social media chatter centers on POET Technologies shares holding steady near $10 following a sharp retreat from earlier peaks. Observers note lighter trading volume and continued consolidation after the prior advance.
Technical Focus: Analysts online emphasize the importance of reclaiming the $12 level with meaningful volume to signal renewed momentum. Many stress the need for confirmation over impulsive moves in this volatile name tied to photonics and AI interconnects.
Catalyst Watch: Participants highlight ongoing interest in potential catalysts that could drive the next leg higher, while advising patience amid the current range-bound action.
Note: This discussion summary was generated from an AI condensation of post data.
POET Technologies Hedge Fund Activity
We have seen 67 institutional investors add shares of POET Technologies stock to their portfolio, and 58 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MMCAP INTERNATIONAL INC. SPC removed 2,059,035 shares (-57.4%) from their portfolio in Q4 2025, for an estimated $13,033,691
- CITADEL ADVISORS LLC added 1,851,618 shares (+273.0%) to their portfolio in Q1 2026, for an estimated $10,998,610
- GROUP ONE TRADING LLC added 1,196,057 shares (+inf%) to their portfolio in Q1 2026, for an estimated $7,104,578
- TUDOR INVESTMENT CORP ET AL added 978,082 shares (+inf%) to their portfolio in Q1 2026, for an estimated $5,809,807
- MILLENNIUM MANAGEMENT LLC added 718,952 shares (+inf%) to their portfolio in Q1 2026, for an estimated $4,270,574
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 607,885 shares (-88.6%) from their portfolio in Q1 2026, for an estimated $3,610,836
- TREXQUANT INVESTMENT LP added 584,690 shares (+inf%) to their portfolio in Q1 2026, for an estimated $3,473,058
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
